ESR1 and neoplasm: As already discussed, treatment decision for patients with breast cancer is based on prognostic clinical-pathological parameters (e.g., age, tumor size, presence of node metastases and histological grade), in addition to predictive factors for response to the treatment (ER/PgR and HER2).